Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 17251961 | NIR-II EMISSIVE LUMINOGENS | December 2020 | March 2024 | Allow | 39 | 1 | 0 | Yes | No |
| 17115326 | LEVELS OF BCMA PROTEIN EXPRESSION ON B CELLS AND USE IN DIAGNOSTIC METHODS OF TREATING SYSTEMIC LUPUS ERYTHEMATOSUS | December 2020 | October 2023 | Abandon | 34 | 2 | 0 | No | No |
| 17104166 | COMPOSITIONS AND METHODS FOR CHEMICAL SYNTHESIS | November 2020 | February 2024 | Allow | 39 | 1 | 1 | Yes | No |
| 17001857 | METHODS FOR DETECTING CCR2 RECEPTORS | August 2020 | February 2024 | Allow | 41 | 3 | 1 | Yes | No |
| 16999818 | STRONGLY LEWIS ACIDIC METAL-ORGANIC FRAMEWORKS FOR CONTINUOUS FLOW CATALYSIS | August 2020 | March 2024 | Allow | 43 | 2 | 1 | No | No |
| 16896742 | POLYCYCLOCARBONATE COMPOUNDS AND POLYMERS AND COMPOSITIONS FORMED THEREFROM | June 2020 | April 2024 | Allow | 46 | 1 | 0 | No | No |
| 16761602 | FLUORESCENT PROBES FOR SILVER ION DETECTION | May 2020 | March 2024 | Allow | 47 | 3 | 1 | Yes | No |
| 16855957 | COMPOSITIONS AND METHODS OF USE FOR ALPHA-1 ANTITRYPSIN HAVING NO SIGNIFICANT SERINE PROTEASE INHIBITOR ACTIVITY | April 2020 | May 2022 | Abandon | 25 | 1 | 0 | No | No |
| 16755359 | EPIDERMAL PENETRATION TYPE INK COMPOSITION | April 2020 | May 2024 | Allow | 49 | 3 | 1 | No | No |
| 16781025 | PROCESSES FOR THE PRODUCTION OF FLUOROPROPANES AND HALOPROPENES | February 2020 | September 2022 | Abandon | 32 | 1 | 0 | No | No |
| 16609136 | Peptide-Containing Adjuvant Compounds Having PEG Spacers | October 2019 | February 2024 | Allow | 52 | 2 | 1 | Yes | No |
| 16573570 | COMPOSITIONS AND METHODS FOR IMAGING CELLS | September 2019 | April 2024 | Allow | 55 | 6 | 1 | No | No |
| 16265386 | SOLID-SUPPORTED CATALYST FOR CROSS-COUPLING | February 2019 | June 2019 | Allow | 4 | 1 | 0 | No | No |
| 16265425 | ARYL HALIDE CROSS-COUPLING METHOD AND PRODUCT MADE THEREFROM | February 2019 | June 2019 | Allow | 4 | 1 | 0 | No | No |
| 16210163 | [4-(1,3,3-TRIMETHYL-2-OXO-3,4-DIHYDRO-1H-QUINOXALIN-7-YL)PHENOXY]ETHYLOXY COMPOUND OR SALT THEREOF | December 2018 | May 2019 | Allow | 5 | 1 | 0 | No | No |
| 16210066 | PROCESS FOR PREPARING CYCLOPHOSPHAMIDE, INTERMEDIATES, AND MONOHYDRATE THEREOF | December 2018 | September 2019 | Allow | 10 | 0 | 0 | No | No |
| 16179785 | PRE-TARGETING STRATEGIES FOR MOLECULAR IMAGING AND/OR RADIOIMMUNOTHERAPY | November 2018 | February 2024 | Allow | 60 | 6 | 1 | Yes | No |
| 16093508 | METHODS OF TREATING BREAST CANCER | October 2018 | March 2024 | Allow | 60 | 7 | 1 | Yes | No |
| 16078396 | TOXIN AND METHOD FOR PREPARING INTERMEDIATE THEREOF | August 2018 | August 2019 | Allow | 12 | 0 | 0 | No | No |
| 16076797 | SUBSTITUTED IMIDAZOLYLCARBOXAMIDES AS PESTICIDES | August 2018 | July 2019 | Allow | 11 | 0 | 0 | No | No |
| 16054713 | BIOFILM INHIBITING COMPOSITIONS ENHANCING WEIGHT GAIN IN LIVESTOCK | August 2018 | March 2019 | Allow | 8 | 1 | 0 | No | No |
| 16029455 | ELECTRIC WIRE FOR HIGH FREQUENCY, HIGH VOLTAGE AND LARGE CURRENT | July 2018 | November 2020 | Allow | 28 | 2 | 0 | No | No |
| 15922376 | BETA-LACTAMASE INHIBITORS | March 2018 | January 2019 | Allow | 10 | 1 | 0 | No | No |
| 15759600 | MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE | March 2018 | July 2019 | Allow | 16 | 1 | 0 | No | No |
| 15915415 | Boron-Containing Diacylhydrazine Compounds | March 2018 | October 2019 | Allow | 19 | 1 | 1 | No | No |
| 15748557 | CYCLIC DIARYLBORON DERIVATIVES AS NLRP3 INFLAMMASOME INHIBITORS | January 2018 | October 2019 | Allow | 20 | 1 | 1 | No | No |
| 15864650 | GOLD(I) COMPLEXES, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF TREATING PROLIFERATIVE DISORDERS | January 2018 | November 2018 | Allow | 11 | 1 | 0 | No | No |
| 15831357 | XYLANASES, NUCLEIC ACIDS ENCODING THEM AND METHODS FOR MAKING AND USING THEM | December 2017 | February 2020 | Abandon | 27 | 1 | 0 | No | No |
| 15801781 | NOVEL CRYSTALLINE FORMS | November 2017 | August 2019 | Allow | 21 | 2 | 0 | No | No |
| 15792777 | VOLTAGE CONVERSION MODULE AND BOBBIN | October 2017 | July 2020 | Allow | 33 | 2 | 0 | Yes | No |
| 15709031 | LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | September 2017 | January 2020 | Abandon | 28 | 2 | 0 | No | No |
| 15706785 | POWER CONVERSION SYSTEM | September 2017 | January 2021 | Allow | 40 | 3 | 0 | Yes | Yes |
| 15558106 | METHOD FOR CALIBRATING A POLARISATION AXIS MEASURING DEVICE AND METHOD FOR DETERMINING POLARISATION AXES OF SPECTACLE LENSES FOR A POLARISATION AXIS MEASURING DEVICE | September 2017 | August 2018 | Allow | 11 | 1 | 0 | Yes | No |
| 15532298 | LUMINESCENT PALLADIUM(0) AND PLATINUM(0) CARBENE COMPLEXES FOR OLEDS | June 2017 | June 2018 | Allow | 12 | 0 | 0 | No | No |
| 15488762 | SELF-ASSEMBLY OF NANOSTRUCTURES | April 2017 | November 2019 | Allow | 31 | 4 | 1 | No | No |
| 15459693 | Zinc or Copper (II) Salt and Use Thereof as a Biocide | March 2017 | December 2017 | Allow | 9 | 2 | 0 | No | No |
| 15452839 | METATHESIS CATALYST | March 2017 | September 2017 | Allow | 7 | 1 | 0 | No | No |
| 15362997 | SOLID-SUPPORTED PALLADIUM (II) COMPLEX AS A HETEROGENEOUS CATALYST FOR CROSS COUPLING REACTIONS AND METHODS THEREOF | November 2016 | January 2019 | Allow | 26 | 1 | 0 | No | No |
| 15314256 | Bi-Nuclear Main Group Metal Phosphorescent Emitter | November 2016 | August 2019 | Allow | 32 | 2 | 1 | No | No |
| 15353453 | PROTECTIVE LAYERS PRODUCED BY SOL GEL PROCESSES | November 2016 | August 2019 | Allow | 33 | 1 | 2 | No | No |
| 15353256 | COLOR CONVERSION FILMS PRODUCED BY UV CURING PROCESSES | November 2016 | August 2019 | Allow | 33 | 1 | 2 | No | No |
| 15353509 | PROTECTIVE LAYERS PRODUCED BY UV CURING PROCESSES | November 2016 | August 2019 | Allow | 33 | 1 | 2 | No | No |
| 15353373 | RED ENHANCEMENT IN WHITE LED DISPLAYS USING UV-CURED COLOR CONVERSION FILMS | November 2016 | August 2019 | Allow | 33 | 1 | 2 | No | No |
| 15332793 | Variants of C-Type Natriuretic Peptide | October 2016 | May 2018 | Abandon | 18 | 1 | 0 | No | No |
| 15282636 | METHOD FOR TREATING PROSTATE CANCER AND/OR GASTROINTESTINAL CANCER | September 2016 | January 2017 | Allow | 4 | 0 | 0 | Yes | No |
| 15281735 | METHOD FOR TREATING A CANCER WITH A MIXED LIGAND GOLD(III) COMPLEXES AS ANTI-CANCER AGENTS | September 2016 | January 2017 | Allow | 3 | 1 | 0 | No | No |
| 15273582 | PROCESS FOR PREPARING IMIDAZOLIUM BASED IONIC LIQUIDS WITH DI-POLYMERIZED OXIRANE BASE | September 2016 | February 2018 | Allow | 17 | 1 | 0 | No | No |
| 15126422 | DESIGN, SYNTHESIS, AND BIOLOGICAL ACTIVITY OF PLATINUM-BENZ[C]ACRIDINE HYBRID AGENTS AND METHODS ASSOCIATED THEREWITH | September 2016 | October 2017 | Allow | 13 | 0 | 0 | No | No |
| 15164002 | PHOSPHINE LIGANDS FOR CATALYTIC REACTIONS | May 2016 | January 2017 | Allow | 8 | 2 | 0 | No | No |
| 15092906 | PHOSPHORESCENT ORGANOMETALLIC IRIDIUM COMPLEX, LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, ELECTRONIC DEVICE, AND LIGHTING DEVICE | April 2016 | July 2018 | Allow | 27 | 1 | 1 | No | No |
| 15027008 | Method for Preparation of Cyano Compounds of the 13th Group with a Lewis Acid | April 2016 | June 2016 | Allow | 3 | 0 | 0 | No | No |
| 15081308 | PALLADIUM(II) COMPLEX FOR CATALYZING SONOGASHIRA COUPLING REACTIONS AND A METHOD THEREOF | March 2016 | November 2016 | Allow | 8 | 1 | 0 | No | No |
| 14916547 | PHOTOLABILE LINKER FOR THE SOLID-PHASE SYNTHESIS OF HYDRAZIDES AND PYRANOPYRAZOLES | March 2016 | August 2017 | Allow | 17 | 1 | 0 | No | No |
| 15056580 | MOLECULAR SWITCHES BASED ON CIS/TRANS ISOMERIZATION OF BF2-COORDINATED AZO COMPOUNDS | February 2016 | October 2017 | Allow | 19 | 1 | 0 | No | No |
| 14907147 | PROCESS FOR THE PREPARATION OF A POLYUNSATURATED KETONE COMPOUND | January 2016 | May 2018 | Allow | 28 | 1 | 1 | No | No |
| 14902514 | PRECISE DELIVERY OF THERAPEUTIC AGENTS TO CELL MITOCHONDRIA FOR ANTI-CANCER THERAPY | December 2015 | February 2018 | Allow | 26 | 1 | 1 | No | No |
| 14898410 | METHOD FOR PRODUCING SALTS HAVING MONOFLUORO-TRICYANOBORATE ANIONS | December 2015 | May 2016 | Allow | 5 | 0 | 0 | No | No |
| 14892451 | RUTHENIUM-BASED COMPLEXES, THEIR PREPARATION AND USE AS CATALYSTS | November 2015 | September 2017 | Allow | 22 | 0 | 0 | No | No |
| 14941167 | METHOD FOR PRODUCING LINEAR PENTENENITRILE | November 2015 | July 2016 | Allow | 8 | 1 | 0 | No | No |
| 14855646 | BORON-CONTAINING DIACYLHYDRAZINE COMPOUNDS | September 2015 | December 2017 | Allow | 27 | 1 | 1 | No | No |
| 14850063 | MIXED LIGAND GOLD(III) COMPLEXES AS ANTI-CANCER AGENTS | September 2015 | August 2016 | Allow | 11 | 0 | 0 | No | No |
| 14774570 | ORGANIC OLIGOMERS OF ACYLGLYCEROL | September 2015 | January 2018 | Allow | 28 | 2 | 0 | No | No |
| 14834420 | PHOSPHINE LIGANDS FOR CATALYTIC REACTIONS | August 2015 | February 2016 | Allow | 6 | 1 | 0 | No | No |
| 14798071 | MIXED LIGAND GOLD(III) COMPLEXES AND METHODS THEREOF | July 2015 | July 2016 | Allow | 12 | 0 | 0 | No | No |
| 14759778 | ORGANIC DYE FOR A DYE SENSITIZED SOLAR CELL | July 2015 | August 2017 | Allow | 26 | 2 | 1 | No | No |
| 14651239 | Process for Preparing Asymmetrical Imidazolium Salts | July 2015 | February 2017 | Allow | 20 | 1 | 0 | No | No |
| 14758421 | DITHIENYLPYRROLE-BASED BIOSENSORS AND METHODS FOR THEIR PREPARATION AND USE | June 2015 | September 2017 | Allow | 27 | 0 | 1 | No | No |
| 14441304 | DIHYDROTHIOPHENE DERIVATIVES AS INSECTICIDAL COMPOUNDS | May 2015 | August 2019 | Allow | 51 | 5 | 1 | No | Yes |
| 14705527 | COPPER-CATALYSED LIGATION OF AZIDES AND ACETYLENES | May 2015 | December 2015 | Allow | 7 | 1 | 0 | No | No |
| 14705627 | N-HETEROCYCLIC CARBENE GOLD COMPLEXES WITH ANTICANCER PROPERTIES AND METHODS OF USE THEREOF | May 2015 | December 2016 | Allow | 20 | 1 | 0 | No | No |
| 14669606 | ORGANIC LIGHT-EMITTING DEVICE AND METHOD OF PRODUCING THE SAME | March 2015 | March 2019 | Allow | 48 | 4 | 0 | Yes | No |
| 14660488 | Variants of C-Type Natriuretic Peptide | March 2015 | May 2018 | Abandon | 38 | 1 | 0 | No | No |
| 14627544 | NUCLEOTIDE SEQUENCES AND CORRESPONDING POLYPEPTIDES CONFERRING MODIFIED PHENOTYPE CHARACTERISTICS IN PLANTS | February 2015 | April 2019 | Allow | 50 | 0 | 1 | No | No |
| 14611943 | PHOSPHINE LIGANDS FOR CATALYTIC REACTIONS | February 2015 | April 2015 | Allow | 3 | 0 | 0 | No | No |
| 14610519 | METHODS FOR PREPARING RUTHENIUM CARBENE COMPLEX PRECURSORS AND RUTHENIUM CARBENE COMPLEXES | January 2015 | December 2016 | Allow | 23 | 1 | 0 | No | No |
| 14417934 | BORON-CONTAINING 5-ARYLIDENE-3,5-DIHYDRO-4H-IMIDAZOL-4-ONES | January 2015 | July 2015 | Allow | 6 | 1 | 0 | No | No |
| 14591819 | STEM CELL CULTURE MEDIUM AND METHOD OF USING SAID MEDIUM AND THE CELLS | January 2015 | August 2016 | Allow | 19 | 1 | 0 | Yes | No |
| 14412888 | Polysilylated Organosilane Compounds | January 2015 | October 2017 | Allow | 33 | 1 | 1 | No | No |
| 14581571 | SYNTHETIC LIGATION REASSEMBLY IN DIRECTED EVOLUTION | December 2014 | May 2018 | Abandon | 40 | 1 | 0 | No | No |
| 14408863 | SILOXANE-BASED PIPE COATINGS | December 2014 | March 2018 | Allow | 39 | 3 | 1 | Yes | No |
| 14572015 | Soft Protease Inhibitors and Pro-Soft Forms Thereof | December 2014 | July 2015 | Allow | 7 | 1 | 0 | No | No |
| 14546661 | PROCESS FOR THE PREPARATION OF PERFLUOROALKYLCYANO- OR PERFLUOROALKYLCYANOFLUOROBORATES | November 2014 | August 2015 | Allow | 9 | 1 | 0 | No | No |
| 14521317 | XYLANASES, NUCLEIC ACIDS ENCODING THEM AND METHODS FOR MAKING AND USING THEM | October 2014 | July 2019 | Abandon | 57 | 2 | 0 | No | No |
| 14507453 | BORON-CONTAINING SMALL MOLECULES | October 2014 | May 2015 | Allow | 8 | 1 | 0 | No | No |
| 14387890 | COMPOSITIONS AND METHODS RELATED TO INHIBITORS OF JAK KINASE | September 2014 | February 2016 | Allow | 17 | 1 | 0 | No | No |
| 14121568 | SYNTHESIS AND STRUCTURE OF 3,5-DIAMINO-2,6-DI-(TERT-BUTYI-NNO-AZOXY) PYRAZINE AS A CRITICAL INTERMEDIATE IN THE SYNTHESIS OF A NOVEL ENERGETIC COMPOUND | September 2014 | January 2017 | Allow | 28 | 1 | 0 | No | No |
| 14484435 | FIBER REINFORCED THERMOPLASTIC SHEETS WITH SURFACE COVERINGS | September 2014 | November 2016 | Abandon | 26 | 1 | 0 | No | No |
| 14461082 | ANTIBODIES TO TROPONIN I AND METHODS OF USE THEREOF | September 2014 | April 2018 | Abandon | 44 | 2 | 0 | No | No |
| 14478581 | METHODS FOR PRODUCING BORYLATED ARENES | September 2014 | June 2018 | Allow | 45 | 2 | 2 | Yes | No |
| 14470362 | IMAGE TRANSFER SHEET | August 2014 | June 2016 | Allow | 22 | 3 | 0 | Yes | Yes |
| 14467625 | PHOSPHINE LIGANDS FOR CATALYTIC REACTIONS | August 2014 | September 2015 | Allow | 13 | 2 | 0 | No | No |
| 14267455 | METHODS FOR PREPARING RUTHENIUM CARBENE COMPLEX PRECURSORS AND RUTHENIUM CARBENE COMPLEXES | May 2014 | January 2017 | Allow | 32 | 1 | 1 | No | No |
| 14353511 | SILYLATED AZULENYL NITRONE SPIN TRAPS AS CHROMOTROPIC SUPEROXIDE DETECTORS | April 2014 | May 2015 | Allow | 13 | 0 | 0 | No | No |
| 14348407 | RUTHENIUM POLYMERISATION CATALYSTS | March 2014 | July 2017 | Allow | 39 | 2 | 1 | Yes | No |
| 14226884 | AZO MEDIATORS AND METHODS OF USE THEREOF | March 2014 | August 2017 | Allow | 40 | 2 | 2 | No | No |
| 14343235 | METAL NICKEL-IMIDAZOLATE CHIRAL NANO CLATHRATE COMPLEX AND PREPARATION METHOD THEREOF | March 2014 | February 2015 | Allow | 12 | 1 | 0 | No | No |
| 14176571 | METHOD FOR PURIFYING A CRUDE PNPNH COMPOUND | February 2014 | September 2015 | Allow | 19 | 1 | 0 | No | No |
| 14174669 | COMPOSITIONS AND METHODS FOR CYTOPROTECTION | February 2014 | August 2014 | Allow | 6 | 1 | 0 | No | No |
| 14000116 | Process to Obtain a Trifluoromethylating Composition | January 2014 | February 2017 | Allow | 42 | 3 | 1 | No | No |
| 14232673 | COMPOUNDS CONTAINING ALKYL-ALKOXY-CYANO-BORATE ANIONS | January 2014 | May 2014 | Allow | 4 | 0 | 0 | No | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for art-unit 3991.
With a 100.0% reversal rate, the PTAB has reversed the examiner's rejections more often than affirming them. This reversal rate is in the top 25% across the USPTO, indicating that appeals are more successful here than in most other areas.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 45.2% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the top 25% across the USPTO, indicating that filing appeals is particularly effective here. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
✓ Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.
✓ Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
Art Unit 3991 is part of Group 3990 in Technology Center 3900. This art unit has examined 483 patent applications in our dataset, with an overall allowance rate of 96.3%. Applications typically reach final disposition in approximately 32 months.
Art Unit 3991's allowance rate of 96.3% places it in the 95% percentile among all USPTO art units. This art unit has a significantly higher allowance rate than most art units at the USPTO.
Applications in Art Unit 3991 receive an average of 1.65 office actions before reaching final disposition (in the 31% percentile). The median prosecution time is 32 months (in the 44% percentile).
When prosecuting applications in this art unit, consider the following:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.